TCA and Digoxin toxicity Flashcards
3 mechanisms of HCO3 in TCA toxicity
- Raises serum pH (decreases proportion of unbound active drug available)
- increases myocardial contractility
- delivers Na ions to cardiac myocytes (overcomes drug induced sodium channel blockade)
TCA Metabolic pathway and T1/2 life
Hepatic metabolism via cytochrome P450
T1/2=1-3d
7 TCA receptors
Na
K
Serotonin/dopamine (5HT/dopamine)
Histamine
anti-alpha 1
anti-Gaba
muscarinic (cholinergic)
3 electrolyte abnormalities associated with Digoxin toxicity
- Hypokalemia (chronic toxicity)
-treat with slow K replacement - Hyperkalemia (acute)
-treat with antidote Digibind - Hypomagnesemia
4 cardiac arrhythmia’s with
- Bidirectional VT
- slow afib w/ complete HB (any AV block)
- New bigeminy
- Junctional tachycardia
3 mechanisms of action of digoxin
- inhibits Na/K+ ATPase pump (increase intracellular Ca–>increases inotropy)
- decreases SA depolarizing and AV conduction
- increases myocardial automaticity and repolarization
Digoxin toxicity antidote
3 cuases of hypotension in TCA toxicity
- alpha 1 blockade -hypotension
- severe acidosis
- CV compromise (Na channek blockade)
ECG findings of TCA toxicity
1.QRS >100ms
2. terminal 40ms RAD (a. Tall R in aVR, R:S ratio in aVR >0.7)
–>PPV 66-81% TCA poisoning
5 clinical signs of TCA toxicity
- AMS
- Hypotension
- Cardiac dysrhythmias
- Seizures
- Hot and crazy (cholinergic effects)
Toxic dose for most TCAs
5 mg/kg
less for some –>nortryptiline, dothepin, doxepin, desipramine
1 pill can kill in peds
Utility of HD in TCA toxicity
Large volume of distribution protein binding, large molecules –> therefor not helpful.
5 2nd/3rd line agents for TCA toxicity
- Hypertonic saline 1-2cc/kg
- benzos -seizure control
- Magnesium - arrhythmia
- Pressors
- intralipid 1-1.5 cc/kg IV bolus
- lidocaine (class IIb—>arrythmia control)
2 treatment goals in TCA toxicity
- Narrow QRS <100ms
- serum pH 7.45-7.55
When to consider activated charcoal in TCA toxicity
acute life threatening ingestions within 1 hr
2 methods for DigiFAB (each for acute and chronic)
Acute:
1. unknown amount ingested- empiric 10-20 vials (20 if cardiac arrest, otherwise 10)
2. amount of digoxin ingested/0.5mg/vial
Chronic:
1. empiric-6 vials
2. (serum digoxin level ng/mL)x(wht in kg)/100 = dose in vials
5 indications for Digifab
- serum level >15ng/ml (acute)
- tachy dysrhythmias
- Brady dysrhythmias
- cardiac arrest
- Hyperkalemia >5meq/l
- Visual impairment- every looks yellow
- hypotension
- acute ingestion >10 mg (0.3 mg/kg)
- Steady state concentration >5ng/mL (chronic)
5/10/15 rule - co-ingestion with other cardiotoxic drugs
5 plants containing cardiac glycosides
- fox gloves
- yellow oleander
- white oleander
- lilly of valley
- Dognbane
- Rhododendron
3 treatment for tachydysrythmias in digoxin toxicity
- cardiovert or defibrilate
- lidocaine (suppresses ventricular automaticity) ***avoid other anti arrythmics, will make problem worse
- magnesium
2 treatments for brady dysrythmias
- Atropine (0.02 mg/kg/dose)
- transcutaneous pacing
3 other anti-depressants that can cause sodium channel blockade
- citalopram
- fluoxetine
- venlafaxine